In patients with low haemoglobin levels before initiating therapy, there is an increased risk of anaemia during treatment with AVAGLIM.
Patsientidel, kellel on enne ravi alustamist madal hemoglobiinitase, on AVAGLIM- ravi ajal suurenenud risk aneemia tekkeks.